Skip to main content
All lobbying filings

ASSOCIATION FOR CLINICAL ONCOLOGY

Lobbying for ASSOCIATION FOR CLINICAL ONCOLOGY

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $250,000.00 expenses · posted Apr 17, 2025

Official filing document

 Bills named in this filing 13
  • S 1261
    CONNECT for Health Act of 2025
  • HR 786
    Preserving Patient Access to Accountable Care Act
  • HR 1509
    Accelerating Kids’ Access to Care Act of 2025
  • S 752
    Accelerating Kids’ Access to Care Act
  • S 705
    Innovation in Pediatric Drugs Act of 2025
  • S 864
    HELP Copays Act
  • S 526
    Pharmacy Benefit Manager Transparency Act of 2025
  • S 932
    Give Kids a Chance Act of 2025
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
  • HR 2484
    Seniors’ Access to Critical Medications Act of 2025
  • HR 2120
    ROCR Value Based Program Act
  • HR 929
    Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
  • S 266
    Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
 Lobbying activity 4
Medicare/Medicaid

S. 1261: CONNECT for Health Act- expands access to telehealth services under Medicare Medicare Physician Payment reforms: H. 879 - Medicare Patient Access and Practice Stabilization Act - Providing automatic inflationary updates to Medicare physician payments. Eliminate budget neutrality requirements. Meaningful changes to the Merit-Based Incentive Payment System (MIPS). Incentivizing the transition to value-based care including H.R. 786 - Preserving Patient Access to Accountable Care Act. Prior authorization reforms including H. 2433 - Reducing Medically Unnecessary Delays in Care Act and reintroduction of the Improving Seniors Timely Access to Care act. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. S. 705 - Innovation in Pediatric Drugs Act - to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations. Preserving the Medicaid Program for cancer patients.

Health Issues

S. 864: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs S. 932: Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 1262: Give Kids a Chance Act - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Oncology Drug Shortages - Mitigate existing drug shortages and prevent future shortages of lifesaving and life-prolonging cancer drugs. HR 2484: Seniors' Access to Critical Medications Act - make permanent a waiver issued by the Centers for Medicare and Medicaid Services (CMS) that allowed for Medicare patients to receive critical medications by mail or allow for caregivers and family members to obtain medications for them. HR 2120/S 1031: ROCR Value Based Program Act - To amend title XVIII of the Social Security Act to create a Radiation Oncology Case Rate Value Based Payment Program exempt from budget neutrality adjustment requirements, and to amend section 1128A of title XI of the Social Security Act to create a new statutory exception for the provision of free or discounted transportation for radiation oncology patients to receive radiation therapy services. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes.

Tobacco

Support banning the sale of menthol cigarettes and flavored cigars

Budget/Appropriations

FY 2025 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP) and palliative care research. FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP). House and Senate Budget Resolutions Indirect cost rate caps at the National Institutes of Health Proposed reorganizations and reductions in force at the Department of Health and Human Service

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem